PMID: 3748888Mar 1, 1986Paper

Adriamycin-induced cardiomyopathy. A rat model

Polish Journal of Pharmacology and Pharmacy
A CzarneckiD Sołtysiak-Pawluczuk

Abstract

A rat model of adriamycin-induced cardiomyopathy was elaborated. Adriamycin (ADR) in three total doses 21, 25 and 30 mg/kg ip injected in 15 equal partial doses caused the loss in body weight and hematocrite values, marked leucopenia and moderate elevation of SGOT activities as well as ECG changes. In histopathological examination cardiomyopathic changes were found in heart samples from rats treated with two higher ADR doses. The dose 25 mg/kg is suggested for further investigations concerning the limitation of ADR toxicity.

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.